<DOC>
	<DOCNO>NCT01941030</DOCNO>
	<brief_summary>CLARITY I pilot study identify clinically appropriate endpoint ( ) large , statistically power pivotal trial treatment patient Critical Limb Ischemia ( CLI ) .</brief_summary>
	<brief_title>Complete Lesion Assessment With Fractional ffR IVUS TechnologY</brief_title>
	<detailed_description>50 subject randomize 1:1 Orbital Atherectomy ( OA ) perform Cardiovascular Systems , Inc. 's Orbital Atherectomy System ( OAS ) follow adjunctive balloon angioplasty ( BA ) vs. BA alone treatment tibial vessel disease , define ≥ 50 % stenosis tibial artery ( AT , PT , TPT , PR ) angiography . All subject correspond wound feed target vessel assess study . Subjects enrol study may roll large pivotal trial , appropriate .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>General Subject 's age ≥ 18 year . Subject acceptable candidate percutaneous intervention Sponsor 's OAS BA accordance label indication instruction use ; Subject willing able sign approve informed consent form ( ICF ) ; Subject willing able attend followup wound care visit . General Subject pregnant planning become pregnant within study period . Subject currently participate investigational drug device study clinically interfere endpoint trial . Subject know sensitivity contrast medium sensitivity adequately premedicated . Uncontrolled allergy nitinol , stainless steel , stent material . Subject know allergy atherectomy lubricant component soybean oil , egg yolk phospholipid , glycerin sodium hydroxide . Subject history bleed diathesis coagulopathy refuse blood transfusion . Subject diagnose chronic renal failure creatinine level &gt; 2.5 , unless dialysis , prior index treatment . Subject plan major surgery ( include major amputation ) schedule within 60 day treatment index limb . Subject plan interventional treatment address stenosis contralateral limb schedule within 60 day index treatment . Subject plan interventional treatment address inflow stenosis ipsilateral limb schedule within 60 day index treatment . Subject previously limb treated part study Angiographic 1 . Target lesion ( ) locate anterior tibial ( AT ) , posterior tibial ( PT ) , tibial peroneal trunk ( TPT ) peroneal ( PR ) artery . 2 . Target lesion ≥ 50 % stenosis angiography . 3 . Subject correspond wound feed target vessel Angiographic 1 . Target limb visual flow foot confirm via distal selective angiography . 2 . Thrombus present suspect target treatment vessel . 3 . Target lesion within bypass graft near previously place stent . 4 . The guide wire pass across target lesion . 5 . Anterograde access lesion possible . 6 . Subject angiographic evidence significant dissection near treatment site . 7 . Interventional treatment intend instent restenosis peripheral vascular site . 8 . Subject 's wound ( ) involve multiple angiosomes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>Orbital Atherectomy</keyword>
	<keyword>Balloon Angioplasty</keyword>
	<keyword>Intravascular Ultrasound ( IVUS )</keyword>
	<keyword>Fractional Flow Reserve ( FFR )</keyword>
	<keyword>Quality Life</keyword>
</DOC>